showed that ILC distribution differed in lymph nodes (LN) of RA patients compared with at-risk patients (defined as patients with RF and/or ACPA positivity, and arthralgia without arthritis) or healthy controls (32). The gene discussed is PRTN3; the disease is rheumatoid arthritis.